检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:任敬远[1] 赵晓东[1] 朱丹[2] 陈伟刚[3] 郑周红[3] 刘鸣[2] 田霖丽[2] 孙亚男[2]
机构地区:[1]吉林省肿瘤医院耳鼻咽喉甲状腺外科,吉林长春130021 [2]哈尔滨医科大学附属第二医院耳鼻咽喉-头颈外科,黑龙江哈尔滨150001 [3]齐齐哈尔市第一医院耳鼻咽喉科,黑龙江齐齐哈尔161000
出 处:《现代肿瘤医学》2012年第10期2012-2016,共5页Journal of Modern Oncology
基 金:黑龙江省博士后启动基金资助项目(NO:2009LRB06-294)
摘 要:目的:克隆反义微小RNA hsa-miR-21并构建其慢病毒表达载体,观察反义寡核苷酸重组慢病毒(ASO-miR-21)对喉癌细胞增殖的调控作用。方法:针对hsa-miR-21核苷酸序列,设计并合成mir-21反义寡核苷酸,将pGCSIL-GFP Vector经双酶切后连接产生pGCSIL-GFP-miR-21慢病毒表达载体,PCR筛选阳性克隆,测序鉴定。pGC-LV-miR-21、pHelper 1.0和pHelper 2.0质粒共转染细胞293T,包装慢病毒。以293T细胞绿色荧光蛋白(green fluorescent protein,GFP)的表达水平测定病毒滴度。采用MTT法及克隆形成实验检测反义miR-21(ASO-miR-21)重组慢病毒对喉癌细胞增殖能力的影响。结果:成功构建反义hsa-miR-21的慢病毒表达载体,采用ASO-miR-21抑制喉癌细胞内高水平表达miR-21的活性后,可显著抑制喉癌细胞增殖。结论:成功构建反义miR-21的慢病毒表达载体,ASO-miR-21可以明显抑制喉癌细胞增殖。Objective:To construct a lentiviral expression vector for antisense oligonucleotid(ASO) has-miR-21 and determine its effect on proliferation of human laryngeal carcinoma cell line.Methods: Towards the miR-21 sequences of human,design and synthesis antisense oligonucleotide miR-21.The recombinant plasmid pGCSIL-GFP-miR-21was confirmed by restriction endonuclease analysis and sequencing.293T cells were cotransfected with the recombinant lentiviral vector together with lentivirus package plasmid mix containing pGC-LV-miR-21,pHelper 1.0 and pHelper 2.0.Virus titer was measured according to the expression level of GFP.MTT assay and colony formation experiment were used to observe the inhibit on percentage of ASO-miR-21 on the proliferation of Hep-2 cells.Results: The lentivirus vector of ASO pGC-LV-miR-21 was successfully constructed and it can inhibit proliferation of Hep-2 cells.Conclusion: The lentivirus vector of ASO-miR-21 was successfully constructed and it can inhibit proliferation of laryngeal carcinoma in vitro.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15